Deals
Wellnex bringing brands such as Pain Away, Wakey Wakey and Nighty Night to UK market shortly after gaining admission to the the AIM market of the London Stock Exchange.
The firms recently announced they will operate as combined company LXE Hearing marketing Eargo’s namesake line and hearX’s Lexie brands. Eargo majority owner Patient Square Capital added $100m to its investment.
Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.
Alliance shareholders overwhelmingly back takeover by DBAY Advisors after improved offer values UK-based firm at £362m.
Venture capital fund backed by Germany's Schwabe has €100m to invest in consumer health startups operating in categories such as sleep and mental health.
Cooper takes another step in its international expansion strategy through a partnership with Romania’s MagnaPharm for the distribution and commercialization of its self-care brand portfolio in Central and Eastern Europe (CEE).
The Aurelius-owned distributor will create a new business unit especially for this purpose, headed up by business director Patrik Hene.
OTC Medical is now the distributor in the Netherlands of Serrix’s self-care brands, including fungal nail brand Mycosan, zinc-based cold sore treatment SoreFiX and children’s skincare brand donttellmum.
Offer valuing struggling UK consumer health player Alliance at £350m has the backing of the company's board of directors.
Stada has made the strongest indication yet that it is preparing for an initial public offering, appointing Andreas Fibig as independent chairman of a board of directors that will be established “in the event of an IPO.”
Deal for fellow Belgian firm Kela will bolster Ceres' consumer health offering in Europe with brands such as Folavit and Hyalo.
Haleon now holds 88% of its China OTC joint venture after acquiring a larger stake in the business from its local partners.
Bayer Consumer Health snaps up digital therapeutic Cara Care for its Precision Health business with an eye to developing its self-care capabilities.
French CDMO Unither has snapped up Marinomed's Carragelose virus-blocking compound, which is used in OTC nasal sprays marketed by leading consumer health players such as Perrigo and Reckitt.
French public sector investment bank Bpifrance's influence over the future strategy of Opella extends to its one seat on the company's board, but not past that, Sanofi confirms as it reports Q3 results.
Bayer hopes Impli's implantable hormone biosensor will reveal self-care opportunities in the areas of stress, sleep, weight management, cardiovascular health, women’s health, or bone health.
After coming under fire from French politicians and workers unions over its proposal to sell a majority stake in its consumer health business to US private-equity firm CD&R, Sanofi has invited the French state in on the deal and made a number of binding commitments to jobs and investment.
Control of Sanofi Consumer Healthcare – recently rebranded as Opella – may soon pass to US private-equity firm CD&R but the French firm looks set to retain a substantial stake in a business which has some big Rx-to-OTC switches in the pipeline.
A leading provider of over-the-counter health and wellbeing products in the DACH region will be created through the merger of Merz Lifecare and Windstar Medical.
Perelel acquiring Loom online platform providing reproductive health, sexual wellness and parenting education. First direct-to-consumer product for Curive Healthcare’s Plum brand formulated for vaginal area dryness.